XERVYTEG
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99205147
- Registration number
- 8115056
- Mark type
- Design + words
- Filed
- 28 May 2025
- Published for opposition
- 09 Dec 2025
- Registered
- 27 Jan 2026
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical products and preparations for medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction, and for treating cancers and diseases, namely, neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Pharmaceuticals for treatment, maintaining and restoring human health in the field of disturbed microbial community, and treatment for dysbiosis, cancers, and diseases, in the nature of neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Biological preparations in the nature of microorganisms used to treat, maintain and restore human health in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, and diseases in the nature of neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases
- Class 010 — Medical apparatus: Medical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devices in the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations, namely, a kit comprising a suspension bag and administration tube set, sold empty; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, namely, syringes, infusion sets, implantable devices sold empty; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medication
Owner
- MAAT PHARMA, Lyon, FR
- MAAT PHARMA, Lyon, FR
- MAAT PHARMA, Lyon, FR
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Nov 2025 — EXAMINER'S AMENDMENT ENTERED
- 12 Nov 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Nov 2025 — EXAMINERS AMENDMENT E-MAILED
- 12 Nov 2025 — EXAMINERS AMENDMENT -WRITTEN
- 18 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Sept 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS